ECSP088395A - Método de producción proteica utilizando compuestos anti-senescencia - Google Patents
Método de producción proteica utilizando compuestos anti-senescenciaInfo
- Publication number
- ECSP088395A ECSP088395A EC2008008395A ECSP088395A ECSP088395A EC SP088395 A ECSP088395 A EC SP088395A EC 2008008395 A EC2008008395 A EC 2008008395A EC SP088395 A ECSP088395 A EC SP088395A EC SP088395 A ECSP088395 A EC SP088395A
- Authority
- EC
- Ecuador
- Prior art keywords
- cell culture
- production method
- protein production
- senescence
- senescence compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Abstract
Se proporcionan métodos para producir una proteína en cultivo celular que comprende un compuesto anti-senescencia, tal como el antioxidante carnosina. De acuerdo con las enseñanzas de la presente invención, las células cultivadas en un medio de cultivo celular que comprende un compuesto anti-senescencia exhiben mayor viabilidad y productividad. Adicionalmente, los cultivos celulares cultivados en presencia de un compuesto anti-senescencia exhiben niveles reducidos de agregados de elevado peso molecular en el medio de cultivo celular.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72957305P | 2005-10-24 | 2005-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088395A true ECSP088395A (es) | 2008-05-30 |
Family
ID=37873105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008395A ECSP088395A (es) | 2005-10-24 | 2008-04-23 | Método de producción proteica utilizando compuestos anti-senescencia |
Country Status (24)
Country | Link |
---|---|
US (1) | US20070110743A1 (es) |
EP (1) | EP1941026B1 (es) |
JP (2) | JP2009512459A (es) |
KR (1) | KR101402634B1 (es) |
CN (1) | CN101297027B (es) |
AR (1) | AR058140A1 (es) |
AU (1) | AU2006306433B2 (es) |
BR (1) | BRPI0617744A2 (es) |
CA (1) | CA2627003C (es) |
CR (1) | CR9897A (es) |
DK (1) | DK1941026T3 (es) |
EC (1) | ECSP088395A (es) |
ES (1) | ES2485374T3 (es) |
HK (1) | HK1120552A1 (es) |
IL (1) | IL190550A (es) |
NI (1) | NI200800111A (es) |
NO (1) | NO20081622L (es) |
PE (1) | PE20070796A1 (es) |
PL (1) | PL1941026T3 (es) |
PT (1) | PT1941026E (es) |
RU (1) | RU2491347C2 (es) |
SI (1) | SI1941026T1 (es) |
TW (1) | TW200736397A (es) |
WO (1) | WO2007050498A2 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2495307T1 (en) | 2006-07-13 | 2018-05-31 | Wyeth Llc | Production of the calibration factor IX with an improved glycolization pattern |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
MY185872A (en) | 2006-09-13 | 2021-06-14 | Abbvie Inc | Cell culture improvements |
TW200902708A (en) * | 2007-04-23 | 2009-01-16 | Wyeth Corp | Methods of protein production using anti-senescence compounds |
TWI610936B (zh) * | 2008-10-20 | 2018-01-11 | 艾伯維有限公司 | 使用蛋白質a親和性層析進行抗體之分離及純化 |
MX2011004201A (es) | 2008-10-20 | 2011-05-24 | Abbott Lab | Desactivacion viral durante purificacion de anticuerpos. |
WO2011018472A2 (en) | 2009-08-14 | 2011-02-17 | Basf Se | Methods in cell cultures, and related inventions, employing certain additives |
US9012178B2 (en) | 2010-08-05 | 2015-04-21 | Amgen Inc. | Dipeptides to enhance yield and viability from cell cultures |
CN103097516B (zh) * | 2010-08-31 | 2015-09-09 | 菲仕兰品牌公司 | 真核细胞培养基 |
EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
TW201247874A (en) * | 2011-05-25 | 2012-12-01 | United Biomedical Inc | Method for producing the activity of bone activating protein |
US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
WO2013176754A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
SG11201504249XA (en) | 2012-09-02 | 2015-07-30 | Abbvie Inc | Methods to control protein heterogeneity |
EP2830651A4 (en) | 2013-03-12 | 2015-09-02 | Abbvie Inc | HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS |
AU2014229557B2 (en) * | 2013-03-13 | 2017-12-07 | Anteis Sa | Peptides for skin rejuvenation and methods of using the same |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
US8921526B2 (en) | 2013-03-14 | 2014-12-30 | Abbvie, Inc. | Mutated anti-TNFα antibodies and methods of their use |
US9499614B2 (en) | 2013-03-14 | 2016-11-22 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides |
AU2014233393B2 (en) * | 2013-03-15 | 2020-05-28 | Genentech, Inc. | Cell culture compositions with antioxidants and methods for polypeptide production |
EP3052640A2 (en) | 2013-10-04 | 2016-08-10 | AbbVie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
WO2015057910A1 (en) | 2013-10-16 | 2015-04-23 | Oncobiologics, Inc. | Buffer formulations for enhanced antibody stability |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
WO2015073884A2 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
CN104398398A (zh) * | 2014-10-27 | 2015-03-11 | 陈少威 | 一种细胞量子动力素(平衡剂)及其使用方法 |
MA40864A (fr) * | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères |
EP3247718B1 (en) | 2015-01-21 | 2021-09-01 | Outlook Therapeutics, Inc. | Modulation of charge variants in a monoclonal antibody composition |
TWI797060B (zh) | 2015-08-04 | 2023-04-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
US11401509B2 (en) | 2015-11-09 | 2022-08-02 | Bristol-Myers Squibb Company | Methods of minimizing glycoprotein agregation in CHO cell production |
WO2017120359A1 (en) * | 2016-01-06 | 2017-07-13 | Oncobiologics, Inc. | Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition |
MX2018009341A (es) | 2016-02-03 | 2019-05-15 | Oncobiologics Inc | Formulaciones tamponadas para una mayor estabilidad de anticuerpos. |
AU2018350890A1 (en) * | 2017-10-16 | 2020-03-19 | Regeneron Pharmaceuticals, Inc. | In situ Raman spectroscopy systems and methods for controlling process variables in cell cultures |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5225539A (en) * | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
EP0939121B2 (de) * | 1989-09-12 | 2007-12-26 | AHP Manufacturing B.V. | TFN-bindende Proteine |
US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
DE69132032T2 (de) * | 1990-11-23 | 2000-12-21 | Peptech Ltd | Verzögerung, verhinderung und/oder rückgängigmachen von zellalterung |
EP0940468A1 (en) * | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
RU2245365C2 (ru) * | 1994-01-03 | 2005-01-27 | Генентек Инк. | Тромбопоэтин |
US5830761A (en) * | 1995-06-07 | 1998-11-03 | Genetics Institute, Inc. | Medium and methods for culturing mammalian cho cells |
RU2134120C1 (ru) * | 1995-06-26 | 1999-08-10 | Безруков Михаил Васильевич | Средство для стабилизации пептидной связи в белковом препарате |
ATE219517T1 (de) * | 1995-08-18 | 2002-07-15 | Morphosys Ag | Protein-/(poly)peptidbibliotheken |
JP4306813B2 (ja) * | 1995-09-19 | 2009-08-05 | アスビオファーマ株式会社 | 動物細胞の新規培養方法 |
US6146847A (en) * | 1996-11-01 | 2000-11-14 | Genespan Corporation | Stabilized transient gene expression |
KR100942002B1 (ko) * | 1996-12-03 | 2010-02-12 | 암젠 프레몬트 인코포레이티드 | 복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린 유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된 항체 |
US20030040095A1 (en) * | 2001-03-16 | 2003-02-27 | Achille Arini | Method for the production of pharmaceutically active recombinant proteins |
AR035869A1 (es) * | 2001-04-24 | 2004-07-21 | Innogenetics Nv | Proteinas de la envoltura de hcv glicosiladas en la estructura central, un metodo para producir la proteina de envoltura de hcv aislada, una composicion que la comprende, metodo para detectar la presencia de anticuerpos anti-hcv en una muestra, un kit de diagnostico para detectar la presencia de ant |
JP4541157B2 (ja) * | 2002-12-23 | 2010-09-08 | ブリストル−マイヤーズ スクイブ カンパニー | タンパク質を製造するための哺乳類細胞培養法 |
US9469672B2 (en) * | 2003-10-27 | 2016-10-18 | Wyeth Llc | Removal of high molecular weight aggregates using hydroxyapatite chromatography |
WO2005064013A1 (en) | 2003-12-23 | 2005-07-14 | Bart Janssen | The use of carnosine metabolism-associated genes to determine genetic predisposition/susceptibility to diabetic nephropathy |
US7294484B2 (en) * | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
US7300773B2 (en) * | 2004-08-27 | 2007-11-27 | Wyeth Research Ireland Limited | Production of TNFR-Ig |
TWI374935B (en) * | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
US7426440B2 (en) * | 2004-09-24 | 2008-09-16 | Nutritional Bioscience Ltd. | Repair and protection factor scoring method for bioactive agents |
-
2006
- 2006-10-23 PE PE2006001284A patent/PE20070796A1/es not_active Application Discontinuation
- 2006-10-23 AR ARP060104624A patent/AR058140A1/es unknown
- 2006-10-24 EP EP06844211.0A patent/EP1941026B1/en active Active
- 2006-10-24 ES ES06844211.0T patent/ES2485374T3/es active Active
- 2006-10-24 JP JP2008537834A patent/JP2009512459A/ja not_active Withdrawn
- 2006-10-24 SI SI200631796T patent/SI1941026T1/sl unknown
- 2006-10-24 CA CA2627003A patent/CA2627003C/en active Active
- 2006-10-24 TW TW095139179A patent/TW200736397A/zh unknown
- 2006-10-24 PT PT68442110T patent/PT1941026E/pt unknown
- 2006-10-24 WO PCT/US2006/041256 patent/WO2007050498A2/en active Application Filing
- 2006-10-24 BR BRPI0617744-1A patent/BRPI0617744A2/pt not_active Application Discontinuation
- 2006-10-24 US US11/585,607 patent/US20070110743A1/en not_active Abandoned
- 2006-10-24 RU RU2008113220/10A patent/RU2491347C2/ru active
- 2006-10-24 CN CN2006800396267A patent/CN101297027B/zh active Active
- 2006-10-24 AU AU2006306433A patent/AU2006306433B2/en active Active
- 2006-10-24 DK DK06844211.0T patent/DK1941026T3/da active
- 2006-10-24 KR KR1020087009856A patent/KR101402634B1/ko active IP Right Grant
- 2006-10-24 PL PL06844211T patent/PL1941026T3/pl unknown
-
2008
- 2008-04-01 IL IL190550A patent/IL190550A/en active IP Right Grant
- 2008-04-02 NO NO20081622A patent/NO20081622L/no not_active Application Discontinuation
- 2008-04-09 NI NI200800111A patent/NI200800111A/es unknown
- 2008-04-18 CR CR9897A patent/CR9897A/es not_active Application Discontinuation
- 2008-04-23 EC EC2008008395A patent/ECSP088395A/es unknown
- 2008-12-03 HK HK08113179.8A patent/HK1120552A1/xx unknown
-
2013
- 2013-04-26 JP JP2013094315A patent/JP5907928B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
IL190550A (en) | 2017-01-31 |
HK1120552A1 (en) | 2009-04-03 |
RU2008113220A (ru) | 2009-12-10 |
WO2007050498A2 (en) | 2007-05-03 |
PE20070796A1 (es) | 2007-08-15 |
AU2006306433A1 (en) | 2007-05-03 |
CN101297027A (zh) | 2008-10-29 |
CN101297027B (zh) | 2013-04-03 |
WO2007050498A3 (en) | 2007-07-12 |
JP2009512459A (ja) | 2009-03-26 |
KR101402634B1 (ko) | 2014-06-03 |
KR20080063365A (ko) | 2008-07-03 |
EP1941026A2 (en) | 2008-07-09 |
RU2491347C2 (ru) | 2013-08-27 |
SI1941026T1 (sl) | 2014-07-31 |
BRPI0617744A2 (pt) | 2011-08-02 |
TW200736397A (en) | 2007-10-01 |
CA2627003A1 (en) | 2007-05-03 |
JP5907928B2 (ja) | 2016-04-26 |
PL1941026T3 (pl) | 2014-12-31 |
AR058140A1 (es) | 2008-01-23 |
AU2006306433B2 (en) | 2013-04-18 |
NI200800111A (es) | 2009-03-03 |
NO20081622L (no) | 2008-06-18 |
CA2627003C (en) | 2018-08-28 |
EP1941026B1 (en) | 2014-06-04 |
US20070110743A1 (en) | 2007-05-17 |
DK1941026T3 (da) | 2014-07-21 |
IL190550A0 (en) | 2008-11-03 |
CR9897A (es) | 2008-07-29 |
PT1941026E (pt) | 2014-07-31 |
JP2013165728A (ja) | 2013-08-29 |
ES2485374T3 (es) | 2014-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088395A (es) | Método de producción proteica utilizando compuestos anti-senescencia | |
PA8778001A1 (es) | Metodos de produccion de proteinas mediante la utilizacion de compuestos anti-senescencia | |
AU2019268194A1 (en) | Cell culture system | |
AR090822A1 (es) | Composiciones de cultivo de celulas y metodos para la produccion de polipeptidos | |
WO2008060541A3 (en) | In vitro expansion of postpartum-derived cells using microcarriers | |
AR111785A2 (es) | Método in vitro de producción de eritrocitos | |
CO6531436A2 (es) | Métodos de producción de glucoproteínas en cultivos de celulas de mamiferos usando glucocorticoides | |
AR069956A1 (es) | Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas | |
ATE540975T1 (de) | Verbesserte faktor-viii-polypeptid-titer in zellkulturen | |
MX2019015525A (es) | Modificacion genetica de ratas. | |
WO2011133902A3 (en) | Cell culture medium comprising small peptides | |
BR112015023036A2 (pt) | método para preparar um produto alcaloide benzilisoquinolina e célula microbiana engenheirada que produz um produto alcaloide benzilisoquinolina | |
AR109907A2 (es) | Métodos para la producción de proteínas morfogenéticas óseas | |
CO6680636A2 (es) | Método para producir adamts13 recombinante en cultivo celular | |
NO20072719L (no) | Serumfritt cellekulturmedium for pattedyrceller | |
CR11827A (es) | Activadores de glucoquinasa | |
MX356756B (es) | Células madre pluripotentes en microportadores. | |
EP2588594A4 (en) | METHODS FOR CULTURING INDIFFERENCED CELLS USING EXTENDED RELEASE COMPOSITIONS | |
WO2010048417A3 (en) | Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products | |
BRPI0619579B8 (pt) | Métodos para aumentar a expectativa de vida replicativa e/ou estabilidade de uma célula produtora de anticorpo, para expressar um gene de uma célula b codificando a cadeia pesada de ig e/ou cadeia leve de ig, para produzir linhagem de células b, para obter anticorpos, e, método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse | |
EA201170024A1 (ru) | Способы получения высокой плотности жизнеспособных клеток в культуре клеток млекопитающих | |
SG10201809452RA (en) | Cell culture compositions with antioxidants and methods for polypeptide production | |
BR112013028544A2 (pt) | método para produzir um composto derivado de acetil-coa heterólogo | |
CR20160307A (es) | Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas | |
EA201170025A1 (ru) | Способы повышения жизнеспособности и продукции культуры клеток |